PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32790250-0	2020	Dihydroartemisinin/miR-29b combination therapy increases the pro-apoptotic effect of dihydroartemisinin on cholangiocarcinoma cell lines by regulating Mcl-1 expression.	artenimol	85-103	microRNA 29b-1	Homo sapiens	19-26	
32790250-12	2020	CONCLUSIONS: The DHA and miR-29b have a pro-apoptotic effect on cholangiocarcinoma cells through the DHA/miR-29b/Mcl-1 pathway, possibly by upregulating the expression of the pro-apoptotic protein Mcl-1S and thus increasing the proportion of Mcl-1S protein among the total amount of Mcl-1 protein.	artenimol	17-20	microRNA 29b-1	Homo sapiens	105-112	
32790250-12	2020	CONCLUSIONS: The DHA and miR-29b have a pro-apoptotic effect on cholangiocarcinoma cells through the DHA/miR-29b/Mcl-1 pathway, possibly by upregulating the expression of the pro-apoptotic protein Mcl-1S and thus increasing the proportion of Mcl-1S protein among the total amount of Mcl-1 protein.	artenimol	101-104	microRNA 29b-1	Homo sapiens	25-32	
32790250-12	2020	CONCLUSIONS: The DHA and miR-29b have a pro-apoptotic effect on cholangiocarcinoma cells through the DHA/miR-29b/Mcl-1 pathway, possibly by upregulating the expression of the pro-apoptotic protein Mcl-1S and thus increasing the proportion of Mcl-1S protein among the total amount of Mcl-1 protein.	artenimol	101-104	microRNA 29b-1	Homo sapiens	105-112	
32790250-2	2020	OBJECTIVES: To investigate the role of DHA and miR-29b on the proliferation and apoptosis of cholangiocarcinoma cells, and to explore whether DHA exerted its role through the miR-29b/Mcl-1 signaling pathway.	artenimol	142-145	microRNA 29b-1	Homo sapiens	175-182	
32790250-7	2020	RESULTS: The DHA increased miR-29b expression in HUCCT-1 and FRH201 cells.	artenimol	13-16	microRNA 29b-1	Homo sapiens	27-34